NEW YORK, August 13, 2026, 2:15 p.m. EDT
- Timken stock rose 1% to $131.56 in afternoon trading.
- Director Richard Kyle sold about $1.73 million of stock on Monday.
- The sale represented just 6.9% of his pre-transaction direct holding.
The Timken Company NYSE:TKR stock rose 1% on Thursday, extending its gain beyond a recent insider sale price. Director and former chief executive Richard Kyle sold 13,637 shares on Monday for a weighted average $126.63, according to a filing made Tuesday.
The transaction was worth about $1.73 million. Yet its scale matters more than the headline. Kyle retained 183,724 directly owned shares, meaning the sale represented only 6.9% of his pre-transaction direct stake.
| Insider transaction | Filed detail |
|---|---|
| Seller | Director Richard G. Kyle |
| Transaction date | August 10, 2026 |
| Shares sold | 13,637 |
| Weighted average price | $126.63 |
| Approximate proceeds | $1.73 million |
| Direct shares retained | 183,724 |
| Pre-sale stake sold | 6.9% |
Timken traded at $131.56 at 2:06 p.m. EDT, 3.9% above Kyle’s sale price. Volume reached about 593,000 shares. The market remained open, and the session range was $129.29 to $131.69.
The stock’s stronger support comes from operations. Timken raised full-year adjusted earnings guidance last week after second-quarter adjusted EPS increased 29%. Organic sales rose 4.4%, while adjusted EBITDA margin expanded 190 basis points.
| Second-quarter metric | 2026 | 2025 | Change |
|---|---|---|---|
| Sales | $1.261 billion | $1.173 billion | +7.5% |
| Adjusted EPS | $1.83 | $1.42 | +28.9% |
| Adjusted EBITDA margin | 19.6% | 17.7% | +190 basis points |
| Free cash flow | $80.5 million | $78.2 million | +2.9% |
Chief Executive Lucian Boldea said improving customer demand and disciplined execution supported the increase. “Our performance during the first half of the year, continued momentum, and disciplined execution framework gives us the confidence to raise our 2026 outlook,” he said. SEC-filed company release
Management lifted the midpoint of adjusted EPS guidance by 20 cents, or 3.3%. It also nudged expected revenue growth higher. The GAAP range fell because second-quarter results included an impairment tied to the planned belts-business divestiture.
| 2026 outlook | May range | August range | Midpoint change |
|---|---|---|---|
| Adjusted EPS | $5.75-$6.25 | $6.05-$6.35 | +$0.20, or +3.3% |
| GAAP EPS | $4.70-$5.20 | $3.75-$4.05 | -$1.05, or -21.2% |
| Revenue growth | About 5% | About 5.5% | +0.5 point |
At Thursday’s price, Timken trades at about 21.2 times the midpoint of 2026 adjusted EPS guidance. The multiple falls to 15.5 times management’s roughly $8.50 adjusted EPS target for 2028. Reaching that target requires about 17% annualized EPS growth over two years.
Industrial Motion supplies the main margin lever. Its quarterly sales climbed 14.6%, while adjusted EBITDA margin reached 23.3%. Management targets a 25% to 27% margin for the segment by 2028, up from 19% in 2025.
| Analyst | Rating | Target | Versus $131.56 | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | $150 | +14.0% | July 21, 2026 |
| Citigroup | Buy | $160 | +21.6% | July 14, 2026 |
| KeyBanc | Overweight | $160 | +21.6% | July 13, 2026 |
| JPMorgan | Overweight | $160 | +21.6% | July 13, 2026 |
| Goldman Sachs | Neutral | $142 | +7.9% | July 10, 2026 |
| S&P Global consensus | Buy | $144.91 average | +10.1% | Latest published set |
Analyst targets now span $129 to $160. The average leaves roughly 10% upside, while the bottom sits below Thursday’s price. That range shows investors are paying for execution before the 2028 margin gains arrive.
Risks: Industrial demand can weaken quickly, while tariffs, raw-material costs and acquisition integration could pressure margins. The second quarter included an $8 million tariff-refund benefit. Failure to sustain organic growth would make the current earnings multiple harder to defend.
Kyle’s sale is notable, but not decisive. He kept most of his direct stake, and the stock moved above his exit price. The larger test is whether Timken can turn its raised 2026 outlook into the 17% annualized EPS growth implied by its 2028 target.
Related articles: Earnings
